Search Results - "Bol, K."

Reflections on the Zhong Guo and the Yi Di with Reference to the Middle Period by Bol, Peter K.

“…＂Identity＂ for a group means both how we are the same and what makes us different from others. During the middle period, from the mid-Tang to the mid-Ming, the…”
Get full text

Case Report: Imaging immune checkpoint inhibitor-induced yin-yang effects in the brain by Bol, K F, Peeters, E, van Herpen, C M L, Westdorp, H, Aarntzen, E H J G

“…Treatment with immune checkpoint inhibitors (ICI) can induce durable responses in cancer patients, but it is commonly associated with serious immune-related…”
Get full text

Phase I/II study of single agent MCLA-128, a full length IgG1 bispecific antibody targeting the HER3 pathway: Overall safety at the recommended phase II dose (R2PD) and preliminary activity in HER2+ metastatic gastric/gastroesophageal junction cancer (GC/GEJ) by Alsina, M., Varga, A., Amatu, A., Schellens, J.H.M., Witteveen, P.O., Boni, V., Moreno, V., Bol, K., Lourbakos, A., Magin Ferrer, M., Wasserman, E.

Get full text

Modeling cancelation of periodic inputs with burst-STDP and feedback by Bol, K., Marsat, G., Mejias, J.F., Maler, L., Longtin, A.

“…Prediction and cancelation of redundant information is an important feature that many neural systems must display in order to efficiently code external…”
Get full text

Deregulated Expression of Insulin-Like Growth Factor 1 in Prostate Epithelium Leads to Neoplasia in Transgenic Mice by DiGiovanni, John, Kiguchi, Kaoru, Frijhoff, Anita, Wilker, Eric, Bol, David K., Beltran, Linda, Moats, Samantha, Ramirez, Angel, Jorcano, Jose, Conti, Claudio

“…Transgenic mice expressing human insulin-like growth factor 1 (IGF-1) in basal epithelial cells of prostate have been characterized. Transgene expression led…”
Get full text

Health-related quality of life analysis in stage III melanoma patients treated with adjuvant dendritic cell therapy by Bloemendal, M., Rietveld, M. J. A., van Willigen, W. W., Gerritsen, W. R., Figdor, C. G., Bonenkamp, J. J., Westdorp, H., Boudewijns, S., Koornstra, R. H. T., Adang, E. M. M., Schreibelt, G., Ottevanger, P. B., de Vries, I. J. M., Bol, K. F.

“…Background Health-related quality of life (HRQoL) is an important issue in the rapidly evolving field of adjuvant treatment for stage III melanoma. Dendritic…”
Get full text

Constitutive expression of insulin-like growth factor-1 in epidermal basal cells of transgenic mice leads to spontaneous tumor promotion by DIGIOVANNI, J, BOL, D. K, WILKER, E, BELTRAN, L, CARBAJAL, S, MOATS, S, RAMIREZ, A, JORCANO, J, KIGUCHI, K

“…Transgenic mice overexpressing insulin-like growth factor-1 (IGF-1) in the basal layer of skin epidermis were generated using the bovine keratin 5 promoter…”
Get full text

532 Skin infiltrating lymphocytes as an early biomarker to predict clinical outcome in stage III melanoma patients receiving adjuvant dendritic cell vaccination by Boudewijns, S, Bol, K, Schreibelt, G, Westdorp, H, Van Rossum, M, Koornstra, R, Van der Graaf, W, Aarntzen, E, Punt, K, Figdor, C, Gerritsen, W, Vries, J. De

Get full text

Optimization of combined temozolomide and peptide receptor radionuclide therapy (PRRT) in mice after multimodality molecular imaging studies by Bison, Sander M., Haeck, Joost C., Bol, K., Koelewijn, S. J., Groen, H. C., Melis, M., Veenland, J. F., Bernsen, M. R., de Jong, M.

“…Background Successful treatments of patients with somatostatin receptor (SSTR)-overexpressing neuroendocrine tumours (NET) comprise somatostatin-analogue…”
Get full text

Tumor development by transgenic expression of a constitutively active insulin-like growth factor I receptor by CARBONI, Joan M, LEE, Adrian V, HURLBURT, Warren, AIXIN LI, SAUJNIER, Mark, VELAPARTHI, Upender, WANG, Cindy, WEN, Mei-Li, WESTHOUSE, Richard A, WINMAN, Mark, ZIMMERMANN, Kurt, RUPNOW, Brent A, HADSELL, Darryl L, WONG, Tai W, ROWLEY, Bruce R, LEE, Francis Y, BOL, David K, CAMUSO, Amy E, GOTTARDIS, Marco, GREER, Ann F, CHING PING HO

“…The insulin-like growth factor I receptor (IGF-IR) is a transmembrane tyrosine kinase that is essential to growth and development and also thought to provide a…”
Get full text

Overexpression of insulin-like growth factor-1 induces hyperplasia, dermal abnormalities, and spontaneous tumor formation in transgenic mice by BOL, D. K, KIGUCHI, K, GIMENEZ-CONTI, I, RUPP, T, DIGIOVANNI, J

“…Transgenic animals were developed to assess the role of insulin-like growth factor 1 (IGF-1) in skin growth, differentiation and organization, as well as its…”
Get full text

Mapping China's History by Bol, Peter K

Get full text

Targeted expression of c-Src in epidermal basal cells leads to enhanced skin tumor promotion, malignant progression, and metastasis by MATSUMOTO, Takashi, JIANGHONG JIANG, KIGUCHI, Kaoru, RUFFINO, Lynnsie, CARBAJAL, Steve, BELTRAN, Linda, BOL, David K, ROSENBERG, Michael P, DIGIOVANNI, John

“…In this study, we generated transgenic mice that overexpressed either a constitutively active human c-src mutant (src(530)) or a wild-type human c-src…”
Get full text

Imaging heterogeneity of peptide delivery and binding in solid tumors using SPECT imaging and MRI by Haeck, J. C., Bol, K., de Ridder, C. M. A., Brunel, L., Fehrentz, J. A., Martinez, J., van Weerden, W. M., Bernsen, M. R., de Jong, M., Veenland, J. F.

“…Background As model system, a solid-tumor patient-derived xenograft (PDX) model characterized by high peptide receptor expression and histological tissue…”
Get full text

458 FINAL RESULTS OF THE PHARMACOKINETICS, EFFICACY, AND SAFETY/TOLERABILITY OF 400 AND 600 MG ONCE-DAILY DOSING OF ACH-1625 (HCV NS3 PROTEASE INHIBITOR) IN HCV GENOTYPE 1 by Detishin, V, Haazen, W, Hooijmaijers, R, Ruppert, M, Bol, K, Robison, H, Robarge, L, Agarwal, A, Deshpande, M, Olek, E

Get full text

Induction of ornithine decarboxylase activity is a necessary step for mitogen-activated protein kinase kinase-induced skin tumorigenesis by FEITH, David J, BOL, David K, CARBONI, Joan M, LYNCH, Mark J, SASS-KUHN, Suzanne, SHOOP, Paula L, SHANTZ, Lisa M

“…A transgenic mouse line overexpressing a constitutively active mutant of MEK1, a downstream effector of Ras, driven by the keratin 14 (K14) promoter, has been…”
Get full text

A Phase I Dose-Ranging Study of the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of AVN944, an IMPDH Inhibitor, in Healthy Male Volunteers by Hamilton, J. Michael, Harding, Matthew W., Genna, Thomas, Bol, David K.

“…A phase I study of AVN944, an inosine monophosphate dehydrogenase (IMPDH) inhibitor, was carried out to assess its safety, tolerability, pharmacokinetics, and…”
Get full text

On the unsupervised analysis of domain-specific Chinese texts by Deng, Ke, Bol, Peter K., Li, Kate J., Liu, Jun S.

“…With the growing availability of digitized text data both publicly and privately, there is a great need for effective computational tools to automatically…”
Get full text

P.2.a.022 Phase 3 dose selection for PNB01, a novel fixed dose combination antidepressant inducing a faster and sustained response by Buntinx, E, Bol, K, van den Berg, P, Haazen, L, de Chaffoy, D

Get full text

Normalization of kinship relations to enrich family network analysis: case study on China biographical database by Li, Bin, Yuan, Yiguo, Lu, Xuehui, Bol, Peter K

“…Abstract Kinship is an important issue in history studies. The kinship database is the key resource to analyze the structure, succession, and evolution of…”
Get full text